Vinpocetine Tablets

This product is a cerebral vasodilator that can inhibit phosphodiesterase activity, increase the effect of c-GMP, a messenger for vascular smooth muscle relaxation, and selectively increase cerebral blood flow. It can also inhibit platelet aggregation, reduce human blood viscosity, enhance red blood cell deformability, improve blood fluidity and microcirculation, promote brain tissue to absorb glucose, increase brain oxygen consumption, and improve brain metabolism.

The main component of this product is vinpocetine. Its chemical name is ethyl (13as, 13bs)-13a-ethyl-2,3,5,6-13a,13bhexahydro-1H-indole[3,2,1-de]pyridine[3,2,1-ij][1,5]naphthylidene-12-carboxylic acid. Its molecular formula is C22H26N2O2. Molecular weight is 350.46.

This product is a light pink film-coated tablet, which appears white after removing the film coating.

It is suitable for sequelae of cerebral infarction, sequelae of cerebral hemorrhage, cerebral arteriosclerosis, etc.

Oral administration: Adults take 5 mg (1 tablet) at a time, 3 times a day, or as directed by a physician.

1 Sometimes rash, urticaria, itching and allergic symptoms may occur, and the drug should be discontinued at this time. 2 Sometimes abdominal pain, diarrhea, loss of appetite and other symptoms may occur. 3 Dizziness, facial flushing, slight decrease in blood pressure, tachycardia, etc. may occur occasionally. 4 Sometimes leukopenia, increased S-GOT, S-GPT, r-GTP, AL-P, blood urea nitrogen, etc. may occur.

It is contraindicated during the acute phase of intracranial hemorrhage.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: 1. Pregnant women or women who may be pregnant are prohibited. 2. Lactating women should use with caution and stop breastfeeding if they must use it. Precautions for the elderly: Not yet clear.

This product should not be used together with heparin.

Protect from light, seal tightly, and store in a cool and dry place.

5mg

36 months.